The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...

In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

The following is a summary of “Multiplex lateral flow test sensitivity and specificity in detecting influenza A, B and ...

Investigators from Mass General Brigham​ have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...

A research team from Queen’s University Belfast has mapped the introduction and spread of the SARS-CoV-2 virus across Ireland ...

SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). Post-acute sequelae of SARS-CoV-2 infection (PASC ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

In their Article, the HDR UK COALESCE Consortium concluded that those who are fully vaccinated against SARS-CoV-2 are less likely to be admitted to hospital and to die with COVID-19.1 If the tests for ...

New research emphasizes the need for ongoing COVID-19 protection for people with weakened immune systems, with scalable tests ...